Yanhong Gu Selected Research

Cytokines

12/2019	Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis.
12/2017	Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis.
1/2017	T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
3/2015	Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
7/2014	Effects of cytokine-induced killer cell treatment in colorectal cancer patients: a retrospective study.
6/2014	Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response.
10/2013	Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis.
10/2012	Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis.
6/2012	The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.
5/2006	The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanhong Gu Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 05/2006
22	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 07/2014
17	Colonic Neoplasms (Colon Cancer) 03/2024 - 04/2014
10	Inflammation (Inflammations) 01/2022 - 11/2013
9	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2014
8	Colitis 01/2022 - 10/2012
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2009
6	Carcinogenesis 01/2019 - 12/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 03/2011
4	Liposarcoma 02/2015 - 03/2011
3	Bites and Stings (Sting) 01/2023 - 01/2021
3	Pneumonia (Pneumonitis) 01/2022 - 12/2019
3	Melanoma (Melanoma, Malignant) 01/2022 - 02/2014
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2020
3	Carcinoma (Carcinomatosis) 01/2022 - 03/2017
3	Kidney Neoplasms (Kidney Cancer) 05/2021 - 02/2009
3	Diarrhea 01/2019 - 07/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2015 - 04/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2014 - 05/2013
2	Infections 02/2024 - 06/2014
2	Mucositis 07/2023 - 01/2022
2	Hepatitis 01/2022 - 11/2021
2	Margins of Excision 01/2022 - 01/2018
2	Arthritis (Polyarthritis) 01/2022 - 11/2013
2	Lymphoma (Lymphomas) 12/2020 - 06/2014
2	Leukemia 12/2020 - 04/2014
2	Body Weight (Weight, Body) 12/2020 - 06/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2020 - 01/2018
2	Fibrosis (Cirrhosis) 12/2019 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 06/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 01/2011
2	Lung Neoplasms (Lung Cancer) 03/2015 - 01/2013
2	Immune System Diseases (Immune Disorders) 05/2013 - 10/2012
1	Microsatellite Instability 04/2024

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 12/2019 - 05/2006
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2013
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 01/2016
6	andrographolideIBA 07/2023 - 06/2014
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2017
6	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 10/2012
5	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 05/2009
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2013
5	InflammasomesIBA 12/2019 - 05/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
4	CateninsIBA 05/2021 - 05/2015
4	apatinibIBA 11/2020 - 01/2019
4	Messenger RNA (mRNA)IBA 11/2020 - 02/2014
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2009
3	Phosphotransferases (Kinase)IBA 03/2024 - 02/2014
3	pembrolizumabIBA 01/2022 - 06/2019
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 12/2015
3	Granzymes (Granzyme)IBA 10/2021 - 01/2017
3	Interleukin-17 (Interleukin 17)IBA 02/2020 - 11/2013
3	Dextran SulfateIBA 01/2017 - 05/2013
3	Sulfonic AcidsIBA 01/2017 - 10/2012
3	icotinibIBA 12/2014 - 06/2013
3	ErbB Receptors (EGF Receptor)IBA 12/2014 - 03/2011
2	regorafenibIBA 03/2024 - 11/2021
2	SHP099IBA 03/2024 - 03/2019
2	Circular RNAIBA 02/2024 - 01/2018
2	sintilimabIBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 01/2023 - 01/2020
2	Circulating Tumor DNAIBA 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2021
2	PhosphopeptidesIBA 01/2022 - 11/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
2	DiterpenesIBA 01/2022 - 12/2016
2	PhosphoproteinsIBA 01/2022 - 01/2021
2	andrographolide sulfonateIBA 10/2021 - 06/2014
2	Long Noncoding RNAIBA 07/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2013
2	Pemetrexed (MTA)FDA Link 11/2020 - 08/2015
2	Protein Tyrosine PhosphatasesIBA 01/2020 - 04/2014
2	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 03/2019 - 04/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 12/2017 - 12/2015
2	Cadherins (E-Cadherin)IBA 03/2017 - 05/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 10/2013
2	AzoxymethaneIBA 01/2017 - 06/2014
2	Sunitinib (Sutent)FDA Link 01/2016 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 05/2009
2	Protein Isoforms (Isoforms)IBA 06/2015 - 05/2015
2	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 05/2015 - 02/2009
2	Interleukin-15 (Interleukin 15)IBA 05/2015 - 02/2009
2	CurcuminIBA 10/2014 - 03/2011
2	Axitinib (AG 013736)IBA 07/2014 - 02/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2014 - 02/2014
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2014 - 01/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2014 - 03/2011
2	Adenosine Triphosphatases (ATPase)IBA 03/2014 - 03/2011

Therapy/Procedure

30	Therapeutics 04/2024 - 04/2010
14	Drug Therapy (Chemotherapy) 02/2024 - 03/2011
11	Immunotherapy 07/2023 - 02/2009
3	Radiotherapy 01/2024 - 12/2011
3	Intraperitoneal Injections 12/2020 - 06/2014
2	Neoadjuvant Therapy 01/2023 - 08/2020
2	Adjuvant Chemotherapy 01/2022 - 01/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021 - 01/2013
2	Renal Dialysis (Hemodialysis) 04/2021 - 11/2019